标题
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
作者
关键词
-
出版物
Pharmaceutics
Volume 14, Issue 5, Pages 954
出版商
MDPI AG
发表日期
2022-04-29
DOI
10.3390/pharmaceutics14050954
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gold (III) Derivatives in Colon Cancer Treatment
- (2022) Agata Gurba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target
- (2022) Ashlynn Ai Li Ler et al. Frontiers in Oncology
- p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
- (2022) Leonel Cardozo de Menezes e Souza et al. Membranes
- Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
- (2021) Jing-Quan Wang et al. DRUG RESISTANCE UPDATES
- Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells
- (2021) Rossana Galassi et al. Frontiers in Chemistry
- In Vitro and In Vivo Effect of Palladacycles: Targeting A2780 Ovarian Carcinoma Cells and Modulation of Angiogenesis
- (2021) Francisco Reigosa-Chamorro et al. INORGANIC CHEMISTRY
- DNA Repair Pathways in Cancer Therapy and Resistance
- (2021) Lan-ya Li et al. Frontiers in Pharmacology
- Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent
- (2021) Tatiana J. Carneiro et al. Metabolites
- Supramolecular metal-based nanoparticles for drug delivery and cancer therapy
- (2021) Xiaomin Jiang et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research
- (2021) Marzieh Sohrabi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pt(IV) Prodrugs with NSAIDs as Axial Ligands
- (2021) Daniil Spector et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
- (2021) Dan Gibson JOURNAL OF INORGANIC BIOCHEMISTRY
- A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
- (2021) Yu Lu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
- (2021) Shirin Hafezi et al. Cancers
- Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments
- (2021) Damiano Cirri et al. Biomedicines
- Advancements in the Use of Platinum Complexes as Anticancer Agents
- (2021) Rajiv Sharma et al. Anti-Cancer Agents in Medicinal Chemistry
- The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity
- (2021) Serah Kimani et al. BIOCHEMICAL PHARMACOLOGY
- Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments
- (2021) Robert Czarnomysy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- (2021) Robert Csaba Kiss et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
- (2021) Philipp Fronik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ruthenium Complexes as Promising Candidates against Lung Cancer
- (2021) Qi Sun et al. MOLECULES
- The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy
- (2021) Alakananda Basu PHARMACOLOGY & THERAPEUTICS
- Gold Compounds and the Anticancer Immune Response
- (2021) Ling Zhou et al. Frontiers in Pharmacology
- Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
- (2021) Christiana M. Neophytou et al. Cancers
- Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
- (2021) Kazi Mustafa Mahmud et al. Pharmaceutics
- Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers
- (2021) W. Douglas Fairlie et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Platinum-based Anticancer Drugs: Unveiling Novel Mechanisms of Action of Conventional Metallodrugs for Improved Therapies
- (2021) Tiziano Marzo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Ru(iii) complexes with pyrazolopyrimidines as anticancer agents: bioactivities and the underlying mechanisms
- (2021) Yun-Qiong Gu et al. DALTON TRANSACTIONS
- Impact of the Pd2Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model
- (2021) Tatiana J. Carneiro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity
- (2021) Marialuisa Piccolo et al. Cancers
- Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes
- (2020) Dianna Truong et al. INORGANIC CHEMISTRY
- Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
- (2020) Golara Golbaghi et al. MOLECULES
- Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties
- (2020) Yi Li et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors
- (2020) Maria S. Legina et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
- (2020) Jiabei Zhou et al. Frontiers in Pharmacology
- Gold(III) Complexes: An Overview on Their Kinetics, Interactions With DNA/BSA, Cytotoxic Activity, and Computational Calculations
- (2020) Snežana Radisavljević et al. Frontiers in Chemistry
- Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes
- (2020) Yiying Gu et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties
- (2020) Ida Landini et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Recent Advances of Gold Compounds in Anticancer Immunity
- (2020) Shuang Yue et al. Frontiers in Chemistry
- Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
- (2020) Maria Grazia Ferraro et al. Cells
- Synergistic co-loading of vincristine improved chemotherapeutic potential of Pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer
- (2020) Saikat Ghosh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells
- (2020) Javier Espino et al. Scientific Reports
- Metabolic Aspects of Palladium(II) Potential Anti-Cancer Drugs
- (2020) Tatiana J. Carneiro et al. Frontiers in Oncology
- The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics
- (2020) Tiziano Marzo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
- (2020) Sang Yeul Lee et al. Drug Design Development and Therapy
- Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
- (2019) Reece G. Kenny et al. CHEMICAL REVIEWS
- Metal-based antitumor compounds: beyond cisplatin
- (2019) Peter V Simpson et al. Future Medicinal Chemistry
- Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs
- (2019) Askar Yimit et al. Nature Communications
- Anticancer activity of palladium-based complexes against triple-negative breast cancer
- (2019) Martin Vojtek et al. DRUG DISCOVERY TODAY
- Potential Anticancer Activity of Auranofin
- (2019) Takefumi Onodera et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T
- (2019) Tidarat Nhukeaw et al. APOPTOSIS
- NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
- (2019) Enzo Alessio et al. MOLECULES
- Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
- (2019) Xiaonan Zhang et al. BIOCHIMIE
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines
- (2019) Thomas Scattolin et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells
- (2019) Dik-Lung Ma et al. MOLECULES
- Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
- (2019) Marialuisa Piccolo et al. Scientific Reports
- Advances in Toxicological Research of the Anticancer Drug Cisplatin
- (2019) Luyu Qi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy
- (2019) Xiaoming Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
- (2019) Ana Rilak Simović et al. COORDINATION CHEMISTRY REVIEWS
- Autophagy-regulating N-heterocycles derivatives as potential anticancer agents
- (2019) Xiaoxia Liang et al. Future Medicinal Chemistry
- Identification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells
- (2018) Guan-Jun Yang et al. CHEMICAL COMMUNICATIONS
- Gold(III) Complexes for Antitumor Applications: An Overview
- (2018) Benoît Bertrand et al. CHEMISTRY-A EUROPEAN JOURNAL
- Mitochondria-targeting Anticancer Metal Complexes
- (2018) Andrea Erxleben CURRENT MEDICINAL CHEMISTRY
- Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents
- (2018) Mousumi Pal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anticancer metallodrugs: where is the next cisplatin?
- (2018) Muhammad Hanif et al. Future Medicinal Chemistry
- Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features
- (2018) JuanJuan Li et al. INORGANIC CHEMISTRY
- Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
- (2018) Sreekanth Thota et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?
- (2018) Chien Yeo et al. MOLECULES
- High in vitro anticancer activity of a dinuclear palladium(II) complex with a 2‑phenylpyridine ligand
- (2018) Qi-Pin Qin et al. INORGANIC CHEMISTRY COMMUNICATIONS
- Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
- (2018) Susan Monro et al. CHEMICAL REVIEWS
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
- (2018) Ke Lin et al. Frontiers in Pharmacology
- Multi-action Pt(IV) anticancer agents; do we understand how they work?
- (2018) Dan Gibson JOURNAL OF INORGANIC BIOCHEMISTRY
- Research progress in modern structure of platinum complexes
- (2017) Linkui Bai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
- (2017) Tatjana Lazarević et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
- (2017) Prakash Thangavel et al. International Journal of Nanomedicine
- Recent development of transition metal complexes with in vivo antitumor activity
- (2017) Jia-Xin Liang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- Metal complexes in cancer therapy – an update from drug design perspective
- (2017) Umar Ndagi et al. Drug Design Development and Therapy
- A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
- (2017) Upendarrao Golla et al. Oncotarget
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
- (2017) Carlo Irace et al. Scientific Reports
- Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse
- (2017) Amir Blazevic et al. Scientific Reports
- Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
- (2016) Jan Hrabeta et al. Anti-Cancer Agents in Medicinal Chemistry
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior
- (2016) Carmen M. Hackl et al. CHEMISTRY-A EUROPEAN JOURNAL
- Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes
- (2016) Yvonne Gothe et al. CHEMISTRY-A EUROPEAN JOURNAL
- Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy
- (2016) Chao He et al. CHEMOTHERAPY
- Comprehensive review on tumour active palladium compounds and structure–activity relationships
- (2016) Md Nur Alam et al. COORDINATION CHEMISTRY REVIEWS
- The development of RAPTA compounds for the treatment of tumors
- (2016) Benjamin S. Murray et al. COORDINATION CHEMISTRY REVIEWS
- Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
- (2016) Gwo Yaw Ho et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metal-based drugs that break the rules
- (2016) Claire S. Allardyce et al. DALTON TRANSACTIONS
- Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents
- (2016) Rui-Rong Ye et al. DALTON TRANSACTIONS
- Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
- (2016) Enzo Alessio EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines
- (2016) Lea S. Flocke et al. INVESTIGATIONAL NEW DRUGS
- Biodistribution of the novel anticancer drug sodium trans -[tetrachloridobis(1 H -indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action
- (2016) Anna K. Bytzek et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
- (2016) Aleksandar Bijelic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine
- (2016) Katie S. Murray et al. JOURNAL OF UROLOGY
- Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
- (2016) Mohammad Abid et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin
- (2016) Cynthia Licona et al. Oncotarget
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60
- (2015) Di Hu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells
- (2015) Saeb Aliwaini et al. CANCER LETTERS
- Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(i)–NHC complex
- (2015) Y. Gothe et al. CHEMICAL COMMUNICATIONS
- Chemical biology of anticancer gold(iii) and gold(i) complexes
- (2015) Taotao Zou et al. CHEMICAL SOCIETY REVIEWS
- Exploring the potential of gold(iii) cyclometallated compounds as cytotoxic agents: variations on the C^N theme
- (2015) B. Bertrand et al. DALTON TRANSACTIONS
- The state-of-play and future of platin drugs
- (2015) M. Apps et al. ENDOCRINE-RELATED CANCER
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
- (2015) Jing Yu et al. MEDICINE
- Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
- (2015) Ileana Dragutan et al. MOLECULES
- Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure
- (2015) Abdel-Rahmene Azzouzi et al. WORLD JOURNAL OF UROLOGY
- TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer
- (2015) A. R. Azzouzi et al. WORLD JOURNAL OF UROLOGY
- Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex
- (2015) Giuseppe Vitiello et al. Journal of Materials Chemistry B
- Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
- (2015) Ningning Liu et al. Oncotarget
- Organoiridium Complexes: Anticancer Agents and Catalysts
- (2014) Zhe Liu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo
- (2014) Ferda Ari et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
- (2014) Anant R. Kapdi et al. CHEMICAL SOCIETY REVIEWS
- Palladium Complexes with 3-Substituted Derivatives of 5-Methyl-5-(4-pyridyl)hydantoins. Synthesis, Study and in vitro Cytotoxicity
- (2014) Adriana Bakalova et al. CROATICA CHEMICA ACTA
- NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels
- (2014) Serena Pillozzi et al. DALTON TRANSACTIONS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Antagonism of mTOR Activity by a Kinetically Inert Rhodium(III) Complex
- (2014) Hai-Jing Zhong et al. ChemPlusChem
- Nanocarriers for delivery of platinum anticancer drugs
- (2013) Hardeep S. Oberoi et al. ADVANCED DRUG DELIVERY REVIEWS
- Platinum Compounds: A Hope for Future Cancer Chemotherapy
- (2013) Imran Ali et al. Anti-Cancer Agents in Medicinal Chemistry
- Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
- (2013) Aaron S. Mansfield et al. ANTI-CANCER DRUGS
- Platinum compounds in children with cancer
- (2013) Antonio Ruggiero et al. ANTI-CANCER DRUGS
- A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy
- (2013) Saeb Aliwaini et al. BIOCHEMICAL PHARMACOLOGY
- Anticancer Cationic Ruthenium Nanovectors: From Rational Molecular Design to Cellular Uptake and Bioactivity
- (2013) Gaetano Mangiapia et al. BIOMACROMOLECULES
- Interaction of Anticancer Ruthenium Compounds with Proteins: High-Resolution X-ray Structures and Raman Microscopy Studies of the Adduct between Hen Egg White Lysozyme and AziRu
- (2013) Alessandro Vergara et al. INORGANIC CHEMISTRY
- Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells
- (2013) Wei Guo et al. INORGANIC CHEMISTRY
- Multi-targeted organometallic ruthenium(II)–arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity
- (2013) Zhigang Wang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Metallomics for drug development: a further insight into intracellular activation chemistry of a ruthenium(iii)-based anticancer drug gained using a multidimensional analytical approach
- (2013) Magdalena Matczuk et al. Metallomics
- Monitoring Survivin Expression in Cancer: Implications for Prognosis and Therapy
- (2013) Rodrigo Santa Cruz Guindalini et al. Molecular Diagnosis & Therapy
- Current Development of Pd(II) Complexes as Potential Antitumor Agents
- (2012) Enjun Gao et al. Anti-Cancer Agents in Medicinal Chemistry
- Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
- (2012) Jinchao Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
- (2012) Joao Carlos Lima et al. Anti-Cancer Agents in Medicinal Chemistry
- Cholesterol-Based Nucleolipid-Ruthenium Complex Stabilized by Lipid Aggregates for Antineoplastic Therapy
- (2012) Luca Simeone et al. BIOCONJUGATE CHEMISTRY
- Ruthenium-based complex nanocarriers for cancer therapy
- (2012) Gaetano Mangiapia et al. BIOMATERIALS
- Next-Generation Anticancer Metallodrugs
- (2012) Seiji Komeda et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Rhodium(III) and iridium(III) complexes as anticancer agents
- (2012) Yvonne Geldmacher et al. INORGANICA CHIMICA ACTA
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
- (2012) Chao Lin et al. PLoS One
- NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer
- (2012) Robert Trondl et al. BMC Pharmacology & Toxicology
- Anticancer Metallotherapeutics in Preclinical Development
- (2011) G. N. Kaluderovic et al. CURRENT MEDICINAL CHEMISTRY
- Transition Metal Based Anticancer Drugs
- (2011) K. Benjamin Garbutcheon-Singh et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- Mammalian multidrug-resistance proteins (MRPs)
- (2011) Andrew J. Slot et al. Essays in Biochemistry
- Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo
- (2011) Engin Ulukaya et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
- (2011) Michael I. Webb et al. INORGANIC CHEMISTRY
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Overcoming cisplatin resistance using gold(III) mimics: Anticancer activity of novel gold(III) polypyridyl complexes
- (2011) Kamalakannan Palanichamy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Ruthenium-based chemotherapeutics: are they ready for prime time?
- (2010) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
- (2010) M. Z. Hernandes et al. CURRENT MEDICINAL CHEMISTRY
- Novel Metals and Metal Complexes as Platforms for Cancer Therapy
- (2010) Michael Frezza et al. CURRENT PHARMACEUTICAL DESIGN
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
- (2010) Petra Heffeter et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Organometallic ruthenium-based antitumor compounds with novel modes of action
- (2010) Wee Han Ang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Regarding ruthenium
- (2010) Simon Higgins Nature Chemistry
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer
- (2009) Shuiping Tu et al. CANCER
- Multidrug resistance-associated proteins and implications in drug development
- (2009) Ya-He Liu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- On the medicinal chemistry of gold complexes as anticancer drugs
- (2009) Ingo Ott COORDINATION CHEMISTRY REVIEWS
- Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
- (2009) Di Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Recent developments in ruthenium anticancer drugs
- (2009) Aviva Levina et al. Metallomics
- Structural basis for the sequence-dependent effects of platinum–DNA adducts
- (2009) Srinivas Ramachandran et al. NUCLEIC ACIDS RESEARCH
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
- (2008) Shu-Feng Zhou et al. CURRENT MEDICINAL CHEMISTRY
- New trends for metal complexes with anticancer activity
- (2008) Pieter CA Bruijnincx et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells
- (2008) Maria Pia Rigobello et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Synthesis and Reactivity of the Aquation Product of the Antitumor Complextrans-[RuIIICl4(indazole)2]−
- (2008) Berta Cebrián-Losantos et al. INORGANIC CHEMISTRY
- Antitumour metal compounds: more than theme and variations
- (2007) Michael A. Jakupec et al. DALTON TRANSACTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started